SLU7 and hepatocellular carcinoma: Thus, the downregulation of SLU7 levels described during chronic liver disease and hepatocellular carcinoma (HCC) explains, in part, the accumulation of DeltaTAp73 transcripts in these pathologic conditions [30], which could contribute to carcinogenesis as demonstrated in mice [51].